Biogened Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	115.12	110.93	95.56	79.62	65.32	48.33
Revenue Growth (YoY)	7.37%	16.09%	20.02%	21.89%	35.15%	3.64%
Cost of Revenue	40	34.28	32.07	22.18	23	15.3
Gross Profit	75.12	76.65	63.49	57.44	42.32	33.04
Selling, General & Admin	67.69	66.88	54.62	41.86	35.29	30.02
Other Operating Expenses	-1.59	0.72	0.7	7.2	2.43	0.65
Operating Expenses	66.1	67.6	55.32	49.06	37.73	30.68
Operating Income	9.01	9.06	8.16	8.38	4.59	2.36
Interest Expense	-2.35	-2.37	-2.16	-1.7	-0.6	-0.86
Interest & Investment Income	0	0	0	0	0.01	0
Other Non Operating Income (Expenses)	-0.23	-0.17	0	-0.32	-0.16	0.06
EBT Excluding Unusual Items	6.43	6.52	6.01	6.36	3.84	1.55
Gain (Loss) on Sale of Investments	-	-	-	-	0.49	-
Gain (Loss) on Sale of Assets	0.28	0.32	0.88	0.03	-0	0.62
Other Unusual Items	0.85	0.85	-	-	-	-
Pretax Income	7.56	7.69	6.89	6.39	4.33	2.18
Income Tax Expense	1.83	1.87	1.79	3.01	2.37	0.93
Net Income	5.73	5.82	5.1	3.38	1.96	1.24
Net Income to Common	5.73	5.82	5.1	3.38	1.96	1.24
Net Income Growth	17.73%	14.22%	50.74%	72.46%	57.92%	-2.37%
Shares Outstanding (Basic)	2	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2	2
EPS (Basic)	2.33	2.37	2.08	1.38	0.80	0.51
EPS (Diluted)	2.33	2.37	2.08	1.38	0.80	0.51
EPS Growth	17.73%	14.22%	50.74%	72.46%	57.92%	-2.37%
Free Cash Flow	1.81	-1.49	7.72	-3.35	1.57	6.88
Free Cash Flow Per Share	0.73	-0.61	3.14	-1.36	0.64	2.80
Dividend Per Share	0.500	0.500	0.500	0.400	-	0.200
Dividend Growth	-	-	25.00%	-	-	-
Gross Margin	65.25%	69.10%	66.44%	72.14%	64.78%	68.35%
Operating Margin	7.83%	8.16%	8.54%	10.52%	7.03%	4.88%
Profit Margin	4.98%	5.25%	5.33%	4.25%	3.00%	2.57%
Free Cash Flow Margin	1.57%	-1.35%	8.08%	-4.21%	2.41%	14.23%
EBITDA	13.28	13.19	11.69	11.31	7.47	6.85
EBITDA Margin	11.54%	11.89%	12.23%	14.21%	11.44%	14.17%
D&A For EBITDA	4.27	4.13	3.52	2.94	2.88	4.49
EBIT	9.01	9.06	8.16	8.38	4.59	2.36
EBIT Margin	7.83%	8.16%	8.54%	10.52%	7.03%	4.88%
Effective Tax Rate	24.18%	24.33%	26.01%	47.09%	54.71%	42.95%
Revenue as Reported	115.12	110.93	95.56	79.62	65.32	48.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.